99957ebf_us_Bulletin___October_16__2013__Research_Summary
[PI / Co-PIs] Philip Lazarus Â [Department(s)] College of Pharmacy Role of Pharmacogenetics on Exemestane Metabolism and Toxicity National Institutes of Health/ National Cancer Institute [Research Summary] 
This study looks at the drug Exemestane (EXE), which has been used as an equally or more effective and less toxic alternative to Tamoxifen in breast cancer patients. As part of the project, the researcher will explore the potential cause for inter-individual variability in the response to EXE by determining the mechanisms used to metabolize the drug.Â
WSU Spokane: WSU Spokane Campus Bulletin - October 16, 2013
Research Summary